Cargando…
IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma
IDH1 mutations frequently occur early in human glioma. While IDH1 mutation has been shown to promote gliomagenesis via DNA and histone methylation, little is known regarding its regulation in antiviral immunity. Here, we discover that IDH1 mutation inhibits virus-induced interferon (IFN) antiviral r...
Autores principales: | Chen, Xueqin, Liu, Jun, Li, Yuqin, Zeng, Yuequan, Wang, Fang, Cheng, Zexiong, Duan, Hao, Pan, Guopeng, Yang, Shangqi, Chen, Yuling, Li, Qing, Shen, Xi, Li, Ying, Qin, Zixi, Chen, Jiahong, Huang, Youwei, Wang, Xiangyu, Lu, Yuli, Shu, Minfeng, Zhang, Yubo, Wang, Guocai, Li, Kai, Lin, Xi, Xing, Fan, Zhang, Haipeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600173/ https://www.ncbi.nlm.nih.gov/pubmed/37880243 http://dx.doi.org/10.1038/s41467-023-42545-3 |
Ejemplares similares
-
CLC-3 and SOX2 regulate the cell cycle in DU145 cells
por: Chen, Jiahong, et al.
Publicado: (2020) -
Progress of oncolytic virotherapy for neuroblastoma
por: Chen, Xiao-Tong, et al.
Publicado: (2022) -
ONCOLYTIC VIROTHERAPY
por: Russell, Stephen J, et al.
Publicado: (2012) -
Delivery and Biosafety of Oncolytic Virotherapy
por: Li, Lizhi, et al.
Publicado: (2020) -
Advances in oncolytic virotherapy
por: Russell, Stephen J., et al.
Publicado: (2022)